Overview


Since the beginning of this year, COVID-19 has posed a threat to human society. As a result, industries are wailing, people are on the back foot, and the supply chain has been distorted. Symptoms of the SARS virus include respiratory and gastrointestinal symptoms, which gradually spread throughout the body, making it necessary to diagnose the virus at an early stage if effective treatment is to be administered. A rapid antigen test kit is used to diagnose the disease. Immune responses are stimulated by antigens, which are molecules capable of stimulating them. All proteins, nucleic acids, and polysaccharides can be antigens. It is predicted that SARS-CoV2 virus will be present based on antigen tests. Immune cells distinguish between proteins that belong to the body and proteins that are foreign to them. In this procedure, a pick is inserted into the nose, a swab is collected, and then dipped into a solution that locates and inactivates the virus. If the test is positive, colored lines appear on the strip. RT-PCR is much more expensive. COVID-19 outbreaks and the subsequent demand for diagnostic tests to determine the presence of SARS-CoV2 virus will drive market growth for rapid antigen test kits. Rapid antigen tests are expected to grow as healthcare infrastructure shifts to combat COVID effects, and as awareness of diagnostic procedures rises in badly hit nations. With new cases reported daily, these nations are experiencing higher administration rates of the test among their populations. As a result of government policies and investments in the private sector, advanced diagnostic tests that can detect and aid COVID treatment mechanisms will become more prevalent. Rapid antigen tests may also boost market growth due to several advantages they possess over reverse transcriptase polymerase chain reactions. A variety of benefits are available, including high accuracy, low cost, stability, and minimal side effects. It is important to note that prevalent misconceptions regarding the efficacy and reliability of the testing kits may hamper the growth of the market. In regions with less internet connectivity and literacy levels, the trend is especially concerning.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Rapid Covid-19 Antigen Test Kit Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Rapid Covid-19 Antigen Test Kit Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Cipla
  • AMEDA Labordiagnostik GmbH
  • Becton Dickinson
  • Beijing Lepu Medical Technology
  • BIOSYNEX SWISS SA
  • CerTest Biotect S.L.
  • Hangzhou Clongene Biotech
  • Healgen Scientific Limited
  • LumiraDX UK Ltd
  • Quidel Corporation
  • SD BIOSENSOR inc
  • Roche
  • Siemens
  • Xiamen Boson Biotech
  • Zehjiang Orient Gene Biotech Co. Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • RT-PCR Assay Kits
  • Immunoassay test Strips
  • Cassettes

By Specimen Type

  • Nasopharyngeal Swab
  • Oropharyngeal Swab
  • Nasal Swab

By Technology

  • Chromatograpic Immunoassay
  • Fluorescent Immunoassay
  • Others

By End User

  • Hospitals
  • Diagnostic laboratories
  • Clinics
  • Homecare
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Rapid Covid-19 Antigen Test Kit Market By Product, By Specimen Type, By Technology, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Rapid Covid-19 Antigen Test Kit Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Rapid Covid-19 Antigen Test Kit Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Rapid Covid-19 Antigen Test Kit Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Rapid Covid-19 Antigen Test Kit Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. RT-PCR Assay Kits
        2. Immunoassay test Strips
        3. Cassettes

  • 8.   Rapid Covid-19 Antigen Test Kit Market, By Specimen Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Nasopharyngeal Swab
        2. Oropharyngeal Swab
        3. Nasal Swab

  • 9.   Rapid Covid-19 Antigen Test Kit Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chromatograpic Immunoassay
        2. Fluorescent Immunoassay
        3. Others

  • 10.   Rapid Covid-19 Antigen Test Kit Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic laboratories
        3. Clinics
        4. Homecare
        5. Others

  • 11.   North America Rapid Covid-19 Antigen Test Kit Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Rapid Covid-19 Antigen Test Kit Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Rapid Covid-19 Antigen Test Kit Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Rapid Covid-19 Antigen Test Kit Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Rapid Covid-19 Antigen Test Kit Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cipla
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AMEDA Labordiagnostik GmbH
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton Dickinson
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Beijing Lepu Medical Technology
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. BIOSYNEX SWISS SA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. CerTest Biotect S.L.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Hangzhou Clongene Biotech
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Healgen Scientific Limited
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. LumiraDX UK Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Quidel Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. SD BIOSENSOR inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Roche
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Siemens
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Xiamen Boson Biotech
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Zehjiang Orient Gene Biotech Co. Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients